Researchers & Healthcare Professionals

www.lls.org/researchershealthcareprofessionals

Cellular Metabolism in Hematologic Malignancies: From Evolving Science to Therapeutic Potential

Note: The free Adobe Acrobat Reader® is required to view and print Adobe PDF files, and the free Windows Media Player or RealPlayer is required to listen to the MP3 audio files.

Internet Release Date: February 28, 2013
CE Credit Available Until: August 28, 2014
CME Credit Available Until: February 28, 2014
Target Audience: Hematologists, oncologists, nurses, social workers and other healthcare professionals
Access: Virtual Lecture

Activity Purpose

This free activity, entitled "Cellular Metabolism in Hematologic Malignancies: From Evolving Science to Therapeutic Potential," consists of a program overview, 5 presentations with Q&A, a Learning Assessment, and an Evaluation form. The content of this virtual lecture is derived from a symposium presented on December 7, 2012, in Atlanta, GA.This activity is designed for hematologists, oncologists, nurses, social workers and other healthcare professionals who wish to enhance their knowledge of advances in cellular metabolism and implications in treating patients with hematologic malignancies.

Educational Objectives

After completing this activity, the participant should be better able to:

  • Describe how metabolic reprogramming contributes to tumor transformation and sustains progression in blood cancer cells
  • Assess the therapeutic potential of targeting metabolic changes as they relate specifically to hematologic malignancies
  • Apply new strategies for incorporating therapies that target metabolism in blood cancers
  • Utilize the information presented from current and future clinical trials that evaluate cancer metabolism in order to better manage patients with hematologic malignancies
  • Explain the basis for therapies that affect cancer cell metabolism

Faculty

Chi V. Dang, MD, PhD
John H. Glick, MD, Professor of Medicine
Director
, Abramson Cancer Center
University of Pennsylvania
Perelman School of Medicine
Philadelphia, PA

Jeffrey C. Rathmell, PhD
Associate Professor
Department of Pharmacology and Cancer Biology
Department of Immunology
Sarah W. Stedman Nutrition and Metabolism Center
Duke University
Durham, NC

Mariusz A. Wasik, MD
Professor
Department of Pathology
University of Pennsylvania
Perelman School of Medicine
Philadelphia, PA

Ayalew Tefferi, MD
Professor of Medicine
Division of Hematology
Mayo Clinic
Rochester, MN

John L. Cleveland, PhD
Professor and Chair
Department of Cancer Biology
The Scripps Research Institute
Jupiter, FL 

Sponsors and Supporters

This activity is jointly sponsored by The Leukemia & Lymphoma Society, RMEI, LLC and Postgraduate Institute for Medicine and supported by an educational grant from Celgene Corporation.

last updated on Thursday, February 28, 2013
btn_sharethis